Cici Wang
Process Development Engineering Vertex Pharmaceuticals
Seminars
Thursday 10th September 2026
Roundtable: Scaling Up iPSC Manufacturing to Commercial Volumes to Enable Larger Patient Populations Without Quality Trade‑Offs
2:00 pm
- Designing a stepwise scale‑up strategy from small‑scale reactors to large, commercial volumes while maintaining critical quality attributes and therapeutic dose requirements
- Integrating cryopreservation, control‑rate freezer capacity, and logistics into the scale‑up plan, so product potency is retained across larger, geographically distributed patient populations
- Coordinating with CDMOs, raw‑material vendors and clinical sites to align manufacturing scale, site procedures and supply chain reliability for late‑stage and commercial delivery
